While most new cervical cancer cases and deaths occur in low- and middle-income countries, weak or non-existent HPV vaccination programs leave women in these regions largely unprotected.
A Lancet Global Health study sheds new light on glaring disparities in addressing this preventable tragedy. From 2006 - 2014, of the 47 million girls and women who received full vaccine course and 59 million who got at least one dose, only between 2 and 7% lived in underdeveloped countries.
Ophira Ginsburg writes that supporters of women's sexual and reproductive rights, maternal health, and HIV/AIDS “should embrace advocates for cervical and other women's cancers, rather than perceiving such groups as potential competitors for limited emotional and financial bandwidth.”
The Lancet Global Health